ANIP expands Cortrophin into acute gout flares with a 90-person sales force as investors watch adoption, spending and 2026 milestones.

This article was originally published in HCPLive® and has been lightly edited. The risk of fractures is almost doubled for individuals with acute calcium pyrophosphate crystal arthritis compared to ...

Researchers will present the first-ever study of fractures and calcium pyrophosphate deposition disease at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting. They ...

A clinical trial led by researchers from Hospital Clínic de Barcelona, the August Pi i Sunyer Biomedical Research Institute ...

A session at the 2024 Pediatric Academic Societies annual meeting reviewed the latest clinical practice guideline for acute bacterial arthritis (ABA) in children, developed by a multidisciplinary ...

An apparent first case of psoriatic arthritis triggered by coronavirus disease 2019 (COVID-19) was reported in a genetically predisposed patient. Doctors in Italy reported what is believed to be the ...

Please provide your email address to receive an email when new articles are posted on . The most frequent cause of death in patients with rheumatoid arthritis-associated interstitial lung disease and ...

The aim of treatment for patients with gout flares is the rapid cessation of pain and inflammation. Standard anti-inflammatory treatments, such as NSAIDs and corticosteroids, might not be effective in ...